e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Tuberculosis and non-TB mycobacterial infection II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment outcome of multi-drug resistant tuberculosis (MDR-TB) patients at a tertiary care center of Northern India.
R. Takhar (KOTA, India), A. Saxena (KOTA, India), S. Khangarot (KOTA, India), R. Garg (KOTA, India), B. Bansiwal (KOTA, India), K. Shringi (KOTA, India)
Source:
International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Session:
Tuberculosis and non-TB mycobacterial infection II
Session type:
Thematic Poster
Number:
4639
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Takhar (KOTA, India), A. Saxena (KOTA, India), S. Khangarot (KOTA, India), R. Garg (KOTA, India), B. Bansiwal (KOTA, India), K. Shringi (KOTA, India). Treatment outcome of multi-drug resistant tuberculosis (MDR-TB) patients at a tertiary care center of Northern India.. 4639
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment centre in western region of India
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
Study of drug resistance profile in Multidrug resistant tuberculosis (MDR TB) patients attending a tertiary care hospital at Mumbai.
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017
Frequency of risk factors for multi-drug resistant tuberculosis among the patients enrolled at multi-drug resistant clinic in a tertiary care hospital, Pakistan
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Clinical and genotypic pattern of multidrug resistant tuberculosis isolated from extrapulmonary tuberculosis cases in tertiary care hospitals in northern India
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011
Treatment outcome of multi-drug resistant tuberculosis treated as outpatient in a tertiary care center
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011
Study of prevalence of drug resistance in tuberculosis (TB) patients attending a tertiary care hospital at Mumbai
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Is prevalence of MDR TB and XDR TB decreasing in a tertiary care hospital in India?
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017
Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia)
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
Prevalence of MDR TB and XDR TB in a tertiary care hospital in India
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Year: 2008
Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Treatment outcome of MDR pulmonary tuberculosis in a tertiary care hospital of Karachi, Pakistan
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015
Pattern of drug resistance and treatment outcome of pulmonary tuberculosis treated at a tertiary care tuberculosis center in India- A retrospective analysis
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
Facilities for treating multidrug-resistant tuberculosis (MDRTB) in Europe
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016
A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate?
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Changing prevalence of MDR TB and XDR TB in a tertiary care hospital in India
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Pattern of drug resistance in TB patients treated at DR TB unit in tertiary care public sector hospital in Karachi Pakistan
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Study on drug sensitivity patterns in tuberculosis in tertiary care in Mumbai
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
Primary drug resistant
Mycobacterium tuberculosis
in a tertiary TB center in Iran
Source: Eur Respir J 2005; 26: Suppl. 49, 651s
Year: 2005
Sputum culture conversion among the first cohorts of MDR-TB patients managed in Nigeria at a tertiary care hospital
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept